About Oxipit
Oxipit is a company based in Vilnius (Lithuania) founded in 2017 by Naglis Ramanauskas, Darius Barusauskas, Jogundas Armaitis, Jonas Bialopetravicius, and Gediminas Peksys was acquired by Sectra in March 2026. Oxipit has raised $6.69 million across 4 funding rounds from investors including EIT Health, Sectra and Taiwania Capital. Oxipit operates in a competitive market with competitors including Perspectum, Qure.ai, Lunit, IXICO and Zebra Medical Vision, among others.
- Headquarter Vilnius, Lithuania
- Founders Naglis Ramanauskas, Darius Barusauskas, Jogundas Armaitis, Jonas Bialopetravicius, Gediminas Peksys
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Formspree, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.69 M (USD)
in 4 rounds
-
Latest Funding Round
$4.9 M (USD), Series A
Jan 20, 2023
-
Investors
EIT Health
& 5 more
-
Employee Count
Not available
-
Acquired by
Sectra
(Mar 05, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Oxipit
Unlock access to complete
Unlock access to complete
Funding Insights of Oxipit
Oxipit has successfully raised a total of $6.69M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $4.9 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oxipit
Oxipit has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include EIT Health, Sectra and Taiwania Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm focusing on technology companies
|
Locked | Locked | Locked | |
|
Seed to growth VC firm funding companies in the Baltics
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Oxipit
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oxipit
Investment portfolio details for Oxipit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oxipit
Detailed financials for Oxipit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oxipit Comparisons
Peer comparison for Oxipit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oxipit
Oxipit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Perspectum, Qure.ai, Lunit, IXICO and Zebra Medical Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
Artificial intelligence solutions for cancer detection and treatment are developed.
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
AI-augmented diagnostic tools for radiology imaging are developed.
|
Detailed competitors of Oxipit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oxipit
Complete news archive for Oxipit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxipit
Oxipit was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Oxipit is headquartered in Vilnius, Lithuania.
Gediminas Peksys is the current CEO of Oxipit. They have also founded this company.
Oxipit is a funded company, having raised a total of $6.69M across 4 funding rounds to date.
Oxipit was founded in 2017 in Vilnius, Lithuania, within the healthcare technology sector. Artificial intelligence solutions for medical image analysis are provided to support doctors. Key offerings include ChestGlass for radiograph comparison and anomaly detection, ChestEye as a computer-aided diagnosis tool identifying enlarged heart, edema, pleural effusion, pulmonary emphysema, and subcutaneous emphysema, and QEye for additional imaging needs. Operations emphasize diagnostic accuracy in radiology.
Oxipit's top competitors include Perspectum, Qure.ai and Deeptek.
Oxipit has 6 investors. Key investors include EIT Health, Sectra, Taiwania Capital, Practica Capital, and CoInvest Capital.